ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Samsung Bioepis Opens New Headquarters contractpharma
January 26, 2021The 52,000-square-foot campus to become the hub of Samsung Bioepis’ drive for accelerated development of next-gen biologic medicines. -
Michigan Governor Snyder Signs Bill Facilitating Patient Access to Interchangeable Biologic Medicine
biospace
March 05, 2018?The?Biotechnology Innovation Organization?(BIO) and?MichBio?commend Governor Rick?Snyder?for signing critical legislation to create a pathway for the substitution of interchangeable biologic medicines, with appropriate communication to patients and physi -
EMA to review Sandoz biosimilars adalimumab and infliximab
europeanpharmaceuticalreview
June 05, 2017Sandoz, a Novartis division, announced that the European Medicines Agency (EMA) has accepted for regulatory review their marketing authorisation applications for biosimilars to AbbVie‘s Humira (adalimumab) and Janssen‘s Remicade (infliximab)...
Pharma Sources Insight January 2025
